20:04 EDT Cathie Wood’s ARK Investment bought 86.9K shares of Crispr Therapeutics today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
- Crispr Therapeutics price target lowered to $95 from $102 at Oppenheimer
- CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
- Crispr Therapeutics price target lowered to $65 from $70 at Wells Fargo
- Crispr Therapeutics price target raised to $52 from $46 at Baird